SCLX
NASDAQ
$7.64
Scilex Holding Company (SCLX)
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company is headquartered in Palo Alto, California.
This company is also listed under the following ticker: SCLXW.
Website: https://www.scilexholding.comSector:
Healthcare
Industry:
Drug Manufacturers - General
Target: $490 (+6313.61%)
Market Cap
$78M
Free Cash Flow Yield
-4.38%
Beta (5Y)
1.01
Price Chart
Valuation
Market Cap$78M
Forward P/E2.66
P/S1.92
P/B28.85
Profitability
Total Revenue (TTM)$34M
Gross Profit (TTM)$20M
EBITDA-$344M
Operating Margin-373.5%
EPS-$43.91
Financial Health
Debt-to-Equity-32.4%
Free Cash Flow Yield-4.38%
Growth & Risk
Beta (5Y)1.01
Sharpe Ratio0.79